Dimerix Stock

Dimerix ROCE

The Return on Capital Employed (ROCE) of Dimerix (DXB.AX) as of Jul 14, 2026 is -231.75 %. In the previous year, Return on Capital Employed (ROCE) was -93.05 % — a change of 149.05% (lower).

ROCE

-231.75 %

YoY

149.05%

Last updated:

In 2026, Dimerix's return on capital employed (ROCE) was -231.75 %, a 149.05% increase from the -93.05 % ROCE in the previous year.

Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Dimerix's Return on Capital Employed (ROCE)

Dimerix's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Dimerix's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Dimerix's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Dimerix’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Dimerix stock

Return on Capital Employed (ROCE) of Dimerix is -231.75 % in 2026.

Access this data via the Eulerpool API

Profitability — Dimerix

All Key Metrics — Dimerix